Breast NeoplasmMBRESCNCT06056414
Study of Anxiety After a Session of Energy Resonance by Cutaneous Stimulation
A study testing Energy Resonance by Cutaneous Stimulation in people with Breast Neoplasm, run by Centre Henri Becquerel at 1 site in France.
Trial summary
Performing a breast macrobiopsy can be extremely delicate and anxiety-provoking. It can have an impact on the course of future examinations. Patients' emotional feelings also have a definite impact on the nursing staff. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Breast Neoplasm
- What is being tested?
- Energy Resonance by Cutaneous Stimulation
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 57 participants
- Where
- 1 siteFrance
- Study dates
- 8 Jan 2024to 9 Jul 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Patient has received full information on the organization and purpose of the research, and has signed an informed consent form.
- Patient over 18 years of age
- Patient undergoing a diagnostic breast macrobiopsy for suspected breast cancer
- Patient undergoing a macro breast biopsy for the first time
- Patient affiliated to or benefiting from a social security schem
Who cannot join
- Patient with a history of breast cancer or other pathologies requiring invasive procedures
- Patient with several lesions to be biopsied
- Patient with psychiatric pathology
- Patient under anxiolytic or psychotropic treatment initiated in the month before the breast macrobiopsy
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Study of the Reduction of Anxiety After a Session of Energy Resonance by Cutaneous Stimulation in the Management of Patients Requiring Breast Macrobiopsy.
Performing a breast macrobiopsy can be extremely delicate and anxiety-provoking. It can have an impact on the course of future examinations.
Patients' emotional feelings also have a definite impact on the nursing staff. The purpose of the MBRESC study is to evaluate Energy Resonance by Cutaneous Stimulation , a manual acupressure technique, in the management of anxiety prior to breast macrobiopsy.
- Conditions
- Breast Neoplasm
- Being tested
- Energy Resonance by Cutaneous Stimulation
- Keywords
- macrobiopsy, anxiety, Energy Resonance by Cutaneous Stimulation
- Medical subject headings
- Breast Neoplasms, Anxiety Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Energy Resonance by Cutaneous StimulationOther
Energy Resonance by Cutaneous Stimulation session
| Study group | Role | What they receive |
|---|---|---|
| Energy Resonance by Cutaneous Stimulation | Experimental | one Energy Resonance by Cutaneous Stimulation session performed before macrobiopsy Receives: Other: Energy Resonance by Cutaneous Stimulation |
What is being measured
The primary outcome is the main question the study is designed to answer.
Evaluation of the reduction in ANXIETY STATE
Evaluation of anxiety before and after RESC session using Spielberger scale
Measured: 1 day
Secondary outcomes (2)
Evaluation of the reduction in ANXIETY STATE
Evaluation of anxiety before and after RESC session using Spielberger scale
Measured: 3 days
Evaluation of the reduction in ANXIETY STATE
Evaluation of anxiety before and after RESC session using Spielberger scale
Measured: 7 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 Sep 2023
- Study start8 Jan 2024
- Primary completion2 Jul 2025
- Study completion9 Jul 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Breast NeoplasmStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 57 participants (actual)
Sponsor and investigators
- Lead sponsor
- Centre Henri Becquerel
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Celine Lemaire, Principal investigator, Centre Henri Becquerel
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06056414
- Sponsor's protocol ID
- CHB23.02
- Acronym
- MBRESC
- Status last verified
- Dec 2025
- First submitted
- 21 Sep 2023
- Last updated
- 2 Jan 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 2 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Study of the Reduction of Anxiety After a Session of Energy Resonance by Cutaneous Stimulation in the Management of Patients Requiring Breast Macrobiopsy.
- ClinicalTrials.gov ID
- NCT06056414
- Acronym / sponsor ID
- MBRESC / CHB23.02
- Conditions
- Breast Neoplasm
- Keywords
- macrobiopsy, anxiety, Energy Resonance by Cutaneous Stimulation
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 57 participants (actual)
- Lead sponsor
- Centre Henri BecquerelUniversity, hospital or other
- Study start
- 8 Jan 2024 (actual)
- Primary completion
- 2 Jul 2025 (actual)
- Study completion
- 9 Jul 2025 (actual)
- First posted
- 28 Sep 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Performing a breast macrobiopsy can be extremely delicate and anxiety-provoking. It can have an impact on the course of future examinations.
Patients' emotional feelings also have a definite impact on the nursing staff. The purpose of the MBRESC study is to evaluate Energy Resonance by Cutaneous Stimulation , a manual acupressure technique, in the management of anxiety prior to breast macrobiopsy.
Study design
- Primary purpose
- Supportive care
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Energy Resonance by Cutaneous Stimulation | Experimental | Other: Energy Resonance by Cutaneous Stimulationone Energy Resonance by Cutaneous Stimulation session performed before macrobiopsy |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Patient has received full information on the organization and purpose of the research, and has signed an informed consent form.
- Patient over 18 years of age
- Patient undergoing a diagnostic breast macrobiopsy for suspected breast cancer
- Patient undergoing a macro breast biopsy for the first time
- Patient affiliated to or benefiting from a social security schem
Key exclusion criteria (4 listed)
- Patient with a history of breast cancer or other pathologies requiring invasive procedures
- Patient with several lesions to be biopsied
- Patient with psychiatric pathology
- Patient under anxiolytic or psychotropic treatment initiated in the month before the breast macrobiopsy
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Energy Resonance by Cutaneous StimulationEnergy Resonance by Cutaneous Stimulation session | Other | Energy Resonance by Cutaneous Stimulation |
Primary outcome
Evaluation of the reduction in ANXIETY STATE
Time frame: 1 day
Evaluation of anxiety before and after RESC session using Spielberger scale
2 secondary outcomes
Evaluation of the reduction in ANXIETY STATE
Time frame: 3 days
Evaluation of the reduction in ANXIETY STATE
Time frame: 7 days
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Jan 2026.
- Individual participant dataSharing planned: No
Related trials for Breast Neoplasm
Active, not recruiting
Streamlined Geriatric and Oncological Evaluation Based On IC Technology
Breast Cancer, Comorbidities and Coexisting Conditions
RecruitingPhase 2
Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort
Invasive Mammary Carcinoma, Metastatic Breast Cancer
Not yet recruitingObservational study
Comparison of Reliability, Time Cost, and Participant Comfort of Lymphedema Assessments in Upper Extremity
Lymphedema, Upper Extremity Lymphedema
RecruitingPhase 3
A Study of Camrelizumab Plus Chemotherapy in Combination With or Without Famitinib as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (BCTOP-T-N01)
TNBC - Triple-Negative Breast Cancer
RecruitingPhase 3
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Celine Lemaire principal investigator
Centre Henri Becquerel
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Energy Resonance by Cutaneous Stimulation in people with Breast Neoplasm, run by Centre Henri Becquerel at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 2 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Evaluation of the reduction in ANXIETY STATE (time frame: 1 day). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jan 2026.